Debnarayan Dutta*

Head-Radiation Oncology, Amrita Institute of Medical Science, Kochi, Kerala, India

*Corresponding Author: Debnarayan Dutta, Head-Radiation Oncology, Amrita Institute of Medical Science, Kochi, Kerala, India.

Received: March 24, 2018; Published: May 02, 2018

Citation: Debnarayan Dutta. “Technologies in Cancer Care: Dilemmas of Aspirations and Expectations”. Acta Scientific Medical Sciences 2.3 (2018).

&nbps;&nbps;In last few decades, cancer care has evolved! So are the expectations of patients and care-givers. And it is rightly so, with advances in technology, and incorporation of it widely in clinical practice; cancer care have changed the way we see cancer as a disease. Cancer patients wish long-term control with no or minimal side effects. With aspiration to have better treatment, high-end technologies have taken entry big time in cancer care. Be it in chemotherapy as form of ‘nano-technology’ or in radiology as ‘PET-MRI’ scan. More precise delivery of chemotherapeutic agents with ‘nano’ technology has claimed to improve pharmacokinetics, and is true to an extent as well. ‘Packets’ of medicine delivered only within the tumour and minimal delivery to adjacent normal healthy tissue is the goal for such chemotherapy delivery techniques. However, too many loose ends are around need to be tied before coming to an affirmative conclusion. One of the ‘real-life’ example of effective and precise fungal infection. This highly toxic medicine is possible to be delivered in effective dosage only after implementation of these effective and precise drug delivery systems. It seems now, after years of research and hype, we have agreed that nano-technology drug delivery may be clinically meaningful in highly toxic medicines like Amphotericin, but may not be useful for many other routinely used anti-cancer agents. Marginal and many times ‘theoretical’ benefits motivates increase usage of similar ‘highly specific’ technologies.

Copyright: © 2018 Debnarayan Dutta. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.